{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
The University of Texas MD Anderson Cancer Center
  • Sign In
  • Live Events
  • Online Courses
  • RSS
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

MD Anderson workforce members:  Select "MD ANDERSON LOGIN" and enter your MD Anderson email address and password.

Guests (all other than MD Anderson workforce members): Select "GUEST LOGIN" and enter your email address and password.

MD ANDERSON LOGIN
GUEST LOGIN




Login

New to MD Anderson Continuing Professional Education? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##






Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numerical character
  • Must contain at least 1 special character


  • -- Select Degree --
  • AA
  • AAS
  • ADN
  • BA
  • BS
  • BSN
  • DDS
  • DMD
  • DMin
  • DNP
  • DO
  • DrPH
  • DVM
  • DVM,PhD
  • EdD
  • JD
  • MA
  • MBA
  • MBBS
  • MBBS,MD
  • MD
  • MD, MBA
  • MD, MPH
  • MD, PhD
  • MDiv
  • MEd
  • MHA
  • MPA
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • Other
  • PharmD
  • PharmD, PhD
  • PhD
  • PsyD

Please enter your degree:

User Agreement

By checking this box, I acknowledge that I have read this Notice and affirmatively consent to the processing of my personal data as described in this Notice. 

 



 




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

AML Pathfinder


ONLINEAML Pathfinder

  • Overview
  • Faculty
  • View Content
  • Support


Date & Location
Friday, July 10, 2020, 12:00 AM - Saturday, July 10, 2021, 11:59 PM

Target Audience
Specialties - General Oncology, Surgical Oncology
Professions - Nurse/APN, Pharmacist, Physician (MD or DO), Physician Assistant

Credits
AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Overview
AML Pathfinder is a 1 hour internet enduring material designed to provide practical guidance regarding incorporating new treatment options integrated with clinical information, data, and guidelines.  


Objectives
At the conclusion of this educational activity, the participant should be able to: 

  1. Review and highlight treatment strategies based on the most current clinical practice guidelines, new approvals and approaches for patients with newly diagnosed acute myeloid leukemia (AML).
  2. Discuss strategies for implementing recent drug approvals and review evidence-based regimens for specific patients with relapsed or refractory AML, including management of toxicities.
  3. Evaluate the prognostic implications of molecular and cytogenic features of AML and discuss applying this information into new treatment strategies in mutation-harboring patients

Accreditation
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 

Additional Information

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 




The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.



Supported by educational grants from AbbVie Inc. and Astellas Pharma Inc.

AML Pathfinder
Go to Site

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
 Privacy policies   

©2020 The University of Texas MD Anderson Cancer Center
See us on Facebook See us on Twitter See us on Linked In See us on Instagram